关键数据
18.330今开
19.290最高
170.49K成交量
亏损市盈率 TTM
179.18市盈率动
--股息TTM
1.28%换手率
18.070昨收
17.870最低
2.61M成交额
亏损市盈率静
1.92市净率
0.00%股息率 TTM
-5.99%ROA
16.24052周最高
2.20量比
-56.38M净利润
13.36M总股本
-0.7916每股收益TTM
0.22Beta
-7.85%ROE
7.87052周最低
7.86%振幅
65.15%毛利率
257.12M总市值
6.17回报/风险
2.86%风险率
操作建议
Anika Therapeutics Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名6/199位。机构持股占比非常高,近一月多位分析师给出公司评级为强力买入。最高目标价19.00。中期看,股价处于上升通道。近一个月,市场表现很强,基本面评分较高,但很强的走势得没有得到技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
Anika Therapeutics Inc评分
压力支撑

由于公司未披露,未能获取相关数据
Anika Therapeutics Inc亮点
亮点风险
Anika Therapeutics Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Anika Therapeutics Inc
ANIK
2
Zimmer Biomet Holdings Inc
ZBH
31
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Anika Therapeutics Inc简介
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
公司代码ANIK
公司Anika Therapeutics Inc
CEOBlanchard (Cheryl Renee)
网址https://anika.com/
公司股东
常见问题
Anika Therapeutics Inc(ANIK)的当前股价是多少?
Anika Therapeutics Inc(ANIK)的当前股价是 19.25。
Anika Therapeutics Inc的股票代码是什么?
Anika Therapeutics Inc的股票代码是ANIK。
Anika Therapeutics Inc股票的52周最高点是多少?
Anika Therapeutics Inc股票的52周最高点是16.24。
Anika Therapeutics Inc股票的52周最低点是多少?
Anika Therapeutics Inc股票的52周最低点是7.87。
Anika Therapeutics Inc的市值是多少?
Anika Therapeutics Inc的市值是257.12M。
现在Anika Therapeutics Inc(ANIK)的股票是买入、持有还是卖出?
根据分析师评级,Anika Therapeutics Inc(ANIK)的总体评级为STRONG BUY,目标价格为19.00。
Anika Therapeutics Inc(ANIK)股票的每股收益(EPS TTM)是多少
Anika Therapeutics Inc(ANIK)股票的每股收益(EPS TTM)是-0.76。